EDGAR Filing Documents for 0001047469-09-001305

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001047469-09-001305

Filing Date

2009-02-17

Accepted

2009-02-13 17:58:57

Documents

Period of Report

2008-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	a2190245z10-k.htm	10-K	1398349
2	EXHIBIT 10.30	a2190245zex-10_30.htm	EX-10.30	19548
3	EXHIBIT 10.60	a2190245zex-10_60.htm	EX-10.60	19576
4	EXHIBIT 10.64	a2190245zex-10_64.htm	EX-10.64	23671
5	EXHIBIT 10.65	a2190245zex-10_65.htm	EX-10.65	21456
6	EXHIBIT 10.66	a2190245zex-10_66.htm	EX-10.66	28273
7	EXHIBIT 10.67	a2190245zex-10_67.htm	EX-10.67	6824
8	EXHIBIT 21.1	a2190245zex-21_1.htm	EX-21.1	3851
9	EXHIBIT 23.1	a2190245zex-23_1.htm	EX-23.1	2870
10	EXHIBIT 31.1	a2190245zex-31_1.htm	EX-31.1	7432
11	EXHIBIT 31.2	a2190245zex-31_2.htm	EX-31.2	7353
12	EXHIBIT 32.1	a2190245zex-32_1.htm	EX-32.1	4742
13	G832624.JPG	g832624.jpg	GRAPHIC	44958
14	G183899.JPG	g183899.jpg	GRAPHIC	27629
15	G355427.JPG	g355427.jpg	GRAPHIC	32472
16	G451143.JPG	g451143.jpg	GRAPHIC	39619
	Complete submission text file	0001047469-09-001305.txt		1745145

Mailing Address

Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000

VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)